Results

Total Results: 3,090 records

Showing results for "drug".

201. Tk2 T4 Common Suspected Infections Tools To Improve Communication And Decisionmaking (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/TK2_T4_Common_Suspected_Infections_Tools_To_Improve_Communication_and_Decisionmaking.docx
     October 01, 2016 - Antibiotics SAY: To return to the big picture, not only are resistant strains proliferating, but new drug … Slide 6 Developing a New Drug Is Expensive SAY: There are many reasons for the lack of development … As this slide shows, using constant dollars as its reference point, the cost of bringing a new drug to … In contrast, a new drug for a chronic problem such as high cholesterol or congestive heart failure will … Yet if antibiotic resistance does develop, it will limit the effective lifespan of the drug.

202. State Variation in Opioid Prescription Fills After Childbirth Among Women Ages 18-44 With Commercial Insurance (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-stat-brief-2-postpartum-opioid-rx.pdf
     March 01, 2024 - Drug Alcohol Depend. 2018;188:288-294. https://pubmed.ncbi.nlm.nih.gov/29807216/. … In SyH-DR, generic drug names were partially synthesized. … Generic drug names in each claim from the source file were replaced with synthetic generic drug names … drug name. … In other words, the drug names in SyH-DR preserve the therapeutic classes observed in a claim in the

203. CMS Data Sets for CAHPS Surveys | Agency for Healthcare Research and Quality
     www.ahrq.gov/cahps/news-and-events/events/ahrq-conference-2015/goldstein-slides.html
     October 01, 2020 - Medicaid Services Slide 2 CMS CAHPS Surveys CAHPS Survey for Medicare Advantage and Prescription Drug … Slide 4 Medicare Advantage and Prescription Drug Plan CAHPS Survey MA & PDP CAHPS survey results … Slide 5 Medicare Advantage and Prescription Drug Plan CAHPS Survey, cont’d.

204. Postdiscalldoc (pdf file)
     www.ahrq.gov/sites/default/files/publications/files/postdiscalldoc.pdf
     February 14, 2013 - : Review: Health history Medicine lists for consistency Medicine list for appropriate dosing, drug-drug … and drug-food interactions, and major side effects Contact sheet DE notes Discharge summary and …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver

205. Postdiscalldoc (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/red/toolkit/postdiscalldoc.pdf
     February 14, 2013 - : Review: Health history Medicine lists for consistency Medicine list for appropriate dosing, drug-drug … and drug-food interactions, and major side effects Contact sheet DE notes Discharge summary and …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver …  No change needed in discharge plan as it relates to the drug therapy  Educated patient/caregiver

206. Oregon Rural Practice-based Research Network | Agency for Healthcare Research and Quality
     www.ahrq.gov/ncepcr/communities/pbrn/registry/oregon-rural-practice-based-research-network.html
     May 06, 2013 - Pregnancy and childbirth, including preterm birth Pulmonary disease/asthma Substance abuse (alcohol and drug … a physical disability; Other health or diesease related interests: Access to care-dental services, drug … sampling policies, medication errors and adverse drug events, patient-centered primary care home, practice

207. Final Progress Report: Addressing methodological and ethical issues in pediatric medication safety research (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/carpenter-report.pdf
     January 01, 2024 - medication safety research is also associated with a unique set of challenges, including issues of drug … Food and Drug Administration. … Safety First: Drug Development in Neonates (Brian Smith) b. … child-reported outcomes; and preventing adverse drug events in pediatric populations. … Adverse Drug Reactions in Children: The Impact on Clinical Care and Prescribing Practices (Jennifer

208. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=376
     January 01, 2024 - Populations Dai D , Feinstein JA , Morrison W Epidemiology of polypharmacy and potential drug-drug … the characteristics and prevalence of exposure of pediatric patients to polypharmacy and potential drug-drug … They found that many PICU patients are exposed to substantial polypharmacy and potential drug-drug interactions … Future research should identify the risk of adverse drug events following specific potential drug-drug … Epidemiology of polypharmacy and potential drug-drug interactions among pediatric patients in ICUs of

209. Use of Electronic Health Records | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/nhqrdr/chartbooks/carecoordination/measure5.html
     June 01, 2018 - systems that allow decision support, by component, 2012-2013 Component 2012 2013 Drug … Allergy Alerts 79 84.5 Drug-Drug Interaction Alerts 78.3 83.9 Drug-Lab Interaction … Alerts 66.6 72.7 Drug Dosing Support 62.9 71.8 Clinical Reminders 57.3 68.1 … Drug-drug interaction alerts, from 78.3% to 83.9%. … Drug-lab interaction alerts, from 66.6% to 72.7%. Drug dosing support, from 62.9% to 71.8%.

210. Final Progress Report: Dissemination of the PPRNet Model for Improving Medication Safety (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/19593-Wessell-draft-1.pdf
     December 30, 2013 - practice performance in five categories of MS: avoiding potentially inappropriate therapy, dosages, drug-drug … interactions, drug-disease interactions, and monitoring of potential adverse events. … Two drug-drug interaction indicators (ACE inhibitors or ARBs with potassium-sparing diuretics in elderly … elderly • Digoxin in the elderly with CHF • H2 blockers based on renal function Avoiding Potential Drug-Drug … and monitoring of potential adverse drug events.

211. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=286
     January 01, 2024 - Overrides of 'definite' anaphylaxis drug-allergy interactions were common and often appropriate. … Drug Saf 2018 Mar;41(3):297-302. doi: 10.1007/s40264-017-0615-1. . … Disease and Health, Risk Cornu P , Phansalkar S , Seger DL High-priority and low-priority drug-drug … comparative retrospective study was to investigate whether alert warnings for high-priority and low-priority drug-drug … High-priority and low-priority drug-drug interactions in different international electronic health record

212. CHIPRA 212 Appendix 2 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-2.pdf
     January 17, 2025 - 2 APPENDIX 2 - INHALED CORTICOSTEROIDS (ICS) ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d05262 DPI 4 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d01296 DPI 4 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d04276 DPI 6 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d00760 MDI 5 and older Y Y N Y ICS NDC Code Brand Name Generic Product Name Route Drug

213. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=445
     January 01, 2024 - Keywords: Medication, Elderly, Adverse Drug Events (ADE) Paddock SM , Adams JL , Hoces de … Scheife RT , Hines LE , Boyce RD Consensus recommendations for systematic evaluation of drug-drug … It concluded that evidence-based clinical decision support for drug–drug interactions (DDIs) requires … Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision … Drug Saf 2015 Feb;38(2):197-206. doi: 10.1007/s40264-014-0262-8..

214. From Quality Measures to Quality Care: Examples of Quality Improvement at Work | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/quality-measures/21st-century/challenges.html
     June 01, 2018 - Preventing Adverse Drug Reactions Preventable adverse drug events cause significant mortality each … LDS Hospital in Salt Lake City, Utah, has taken steps to improve its rate of adverse drug events. … From 1990 to 1993, they discovered that 2.43 percent of hospital patients experienced an adverse drug … These efforts led to a 75-percent decline in adverse drug reactions related to antibiotics. … information; increased availability of needed medications; and routine monitoring of drug distribution

215. Implementing an Ambulatory e-Prescribing System: Strategies Employed and Lessons Learned to Minimize Unintended Consequences (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Devine_83.pdf
     April 06, 2008 - - allergy and drug-drug interaction checking. … of drug-specific monitoring parameters. … The Pharmacy and Therapeutics Committee is overseeing the customization of drug-allergy and drug-drug … Similarly, the team has learned that the classification systems for drug-drug interactions used in the … The top 100 drug interactions: A guide to patient management.

216. Quantitative and Qualitative Analysis of Medication Errors: The New York Experience (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Duthie.pdf
     January 01, 2004 - In one situation, the physician ordered 20 mg of a drug, and the RN administered 20 mL. … Unit-dose dispensing of the drug involved in the error will prevent an error with that drug, but not … The drug was accessed from the automated drug- dispensing unit designated for off-hour use by the nursing … The panel recommended that the unpredictable need for the drug should be anticipated, with the drug … Leape LL, Bates DW, Cullen DJ, et al., Systems analysis of adverse drug events.

217. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=124
     January 01, 2024 - Drug Alcohol Depend 2021 Feb 1;219:108501. doi: 10.1016/j.drugalcdep.2020.108501.. … Research Rashdan S , Yang H , Le T Prevalence and significance of potential pharmacokinetic drug-drug … The overall prevalence of potential drug-drug interactions (DDIs) among patients with lung cancer is … Prevalence and significance of potential pharmacokinetic drug-drug interactions among patients with lung … Clin Drug Investig 2021 Feb;41(2):161-67. doi: 10.1007/s40261-020-00994-4. .

218. AHRQ Intensifies the Battle Against Opioid Misuse in 2017, Commits to More Progress in 2018 | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/blog/ahrqviews/battle-against-opioid-misuse.html
     January 01, 2018 - examined questions surrounding dosing and methods of administering naloxone, a potentially life-saving drug … In another significant advancement, an AHRQ-funded study examining the effects of prescription drug … mandatory-access provisions—systems that require clinicians to query the PDMP prior to prescribing a controlled drug—have … been shown to help reduce prescription drug abuse, specifically related to adults 18–24 years of age

219. Methodological Challenges in Describing Medication Dosing Errors in Children (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/McPhillips.pdf
     January 01, 2004 - Incidence of adverse drug events and potential adverse drug events. Implications for prevention. … Tenfold errors in drug dosage. CMAJ 1988;139(1):12–3. 6. … Medication errors and adverse drug events in pediatric inpatients. … Risk factors for unlicensed and off-label drug use in children outside the hospital. … Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.

220. National Strategy for Quality Improvement in Health Care (continued) | Agency for Healthcare Research and Quality
     www.ahrq.gov/workingforquality/about/agency-specific-quality-strategic-plans/nqs4.html
     November 01, 2016 - National Strategy for Quality Improvement in Health Care (continued) Food and Drug Administration … The Safe Use Initiative is an FDA Center for Drug Evaluation and Research nonregulatory program through … which collaborative cross-health sector projects are created to better manage specific preventable drug … Adverse events from drug use are estimated to result in more than 4 million visits to emergency departments … collaborations between federal agencies and the broader health care community can reduce preventable drug